Skip to content

DOLBY LABORATORIES, INC.

DLB

CIK 0001308547

← back to feed
Revenue (TTM)
$1.43B
+5.9% YoY Q2 Mar 2026
Net Income (TTM)
$286.11M
−2.6% YoY Q2 Mar 2026
EPS Diluted (TTM)
$2.96
−2.6% YoY Q2 Mar 2026
Gross Margin
88.2%
Q2 Mar 2026
Operating Margin
23.2%
Q2 Mar 2026
Net Margin
20.0%
Q2 Mar 2026
Free Cash Flow (TTM)
$201.66M
Q2 Mar 2026
Cash
$594.28M
Q2 Mar 2026
Total Debt
—
Q2 Mar 2026
Shares Outstanding
—
Q2 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings